A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of galantamine
hydrobromide in patients with Alzheimer's disease who have not received or have not responded
to treatment with medication similar to galantamine hydrobromide.